Gene Query: NUB1

Dataset Description Geneva Score
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 45.28
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 45.28
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 42.35
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 35.3
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 35.01
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 28.71
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 27.68
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 27.68
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 26.72
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 26.72
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 25.32
Generation and functional characterization of MDSC-like cells 24.38
RIG-I and MDA5 fRIP during KSHV lytic reactivation 22.97
Transcriptional responses of human insulinoma cells to acute cytokine exposure 22.25
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 21.98
Transcriptomes of oxLDL exposed trained monocytes 21.97
oxLDL exposed trained monocytes 21.97
Effect of Hotair overexpression in human breast cancer cell lines 21.72
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 21.6
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 21.49
HNF1 regulates critical functions of the human epididymis epithelium. 21.49
Effects of rFVIIIFc on human macrophages 20.96
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 20.77
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 20.69
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 20.51
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 20.41
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 20.19
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 20.19
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 19.41
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 19.41
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 18.98
Expression data from miR340 overexpressing human A549 cells 18.82
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 18.15
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 17.9
Identifying the molecular mode of action of itraconazole in colorectal cancer 17.3
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 17.26
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 17.25
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 16.88
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 16.76
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 15.68
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 15.59
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 15.48
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 15.41
Region-specific Innate Antiviral Responses of the Human Epididymis 15.06
Macrophage Ad5f35 M2 Challenge 14.94
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 14.86
Differentially expressed genes post knock down of lincDUSP26 14.79
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 14.68
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 14.5
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 14.5
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 14.31
Ebola virus (EBOV) infection of ARPE-19 cells 14.28
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 14.23
RNA-seq of YB5 cells treated with Proscillaridin A 14.08
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 13.97
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 13.83
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 13.59
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 13.56
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 13.47
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 13.4
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 13.4
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 13.33
Differential Gene Expression between MCF10A and MCF7 cells 13.12
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 12.99
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 12.9
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 12.73
SRSF2 mutations impair hematopoiesis and alter exon recognition 12.72
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 12.44
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 12.36
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 12.35
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 12.19
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 12.16
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 12.15
RNAseq of HEK293 cells after Chtop knockdown 11.99
Co-transcriptional loading of RNA export factors shapes the human transcriptome 11.99
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 11.94
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 11.94
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 11.92
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 11.92
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 11.92
Anti-inflammatory effect of indoleacrylic acid (IA) 11.88
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 11.87
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 11.43
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 11.23
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 10.77
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 10.77
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 10.59
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 10.55
Cellular response to hepatitis E virus (HEV) infection 10.49
3’ Uridylation Expands miRNA Target Repertoire 10.34
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 10.27
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 10.26
Macrophage Ad5f35 PhenoMap 10.14
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 9.98
MHC Transcriptomic landscape at haplotype-specific resolution 9.95
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 9.84
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 9.82
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 9.82
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 9.8
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 9.7
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 9.66
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 9.64
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 9.59
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 9.59
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 9.52
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 9.49
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 9.49
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 9.48
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 9.45
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 9.4
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 9.4
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 9.35
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 9.35
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 9.33
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 9.33
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 9.21
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 9.12
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 9.07
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 9.02
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 8.79
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 8.66
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 8.66
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 8.61
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 8.55
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 8.55
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 8.48
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 8.47
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 8.46
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 8.44
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 8.38
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 8.36
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 8.36
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 8.33
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 8.3
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 8.29
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 8.25
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 8.25
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 8.19
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 8.18
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 8.18
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 8.14
RNA Seq of HMVEC under hypoxia 8.12
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 8.12
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 8.09
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 8.08
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 8.05
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 8.05
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 8.05
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 8.03
Transcriptome of U251 cells overexpression complement component 7 7.95
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 7.86
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 7.81
IMP3 regulated gene expression in breast cancer cells 7.81
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 7.72
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 7.7
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 7.67
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 7.65
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 7.63
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 7.62
RNA sequencing of GlyH-101-treated MCF-7 cell line 7.6
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 7.59
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 7.58
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 7.55
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 7.53
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 7.53
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 7.51
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 7.48
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 7.48
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 7.48
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 7.43
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 7.42
Crizotinib v. DMSO in SW480 cells 7.41
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 7.37
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 7.37
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 7.33
AUF-1 affected genes in human skin cells 7.25
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 7.25
Uridylation by TUT4 and TUT7 marks mRNA for degradation 7.23
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 7.19
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 7.15
Identification of renal resident macrophages across species 7.13
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 7.11
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 7.11
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 7.1
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 7.07
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 7.02
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 7.01
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 7.0
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 6.99
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 6.97
The evolution of N6-methyladenosine in primates 6.97
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 6.95
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 6.93
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 6.93
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 6.93
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 6.9
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 6.9
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 6.9
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 6.9
Primary Human B-cell Temporal Response to CD40L Stimulation 6.88
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 6.85
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 6.8
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 6.77
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 6.76
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 6.76
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 6.72
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 6.72
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 6.69
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 6.58
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 6.57
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 6.56
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 6.55
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 6.53
Be1 and Be2 B cells are transcriptionally distinct 6.52
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 6.5
Total RNA-seq in ALL-SIL upon JQ1 inhibition 6.49
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 6.47
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 6.45
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 6.45
Survival of pancreatic cancer cells lacking KRAS function 6.44
Transcriptome of diurnal human blood neutrophils 6.44
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 6.44
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 6.39
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 6.39
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 6.38
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 6.35
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 6.34
Trans-differentiation of human adult peripheral blood T cells into neurons 6.32
Mapping interactions for the TNIP2 hub protein 6.31
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 6.3
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 6.28
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 6.24
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 6.16
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 6.16
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 6.14
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 6.12
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 6.11
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 6.07
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 6.07
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 6.07
NAPRT activation of macrophages 6.06
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 6.06
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 6.06
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 5.97
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 5.97
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 5.9
Integrating single-cell transcriptomic data across different conditions, technologies, and species 5.87
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 5.78
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 5.76
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 5.76
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 5.73
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 5.68
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 5.68
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 5.59
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 5.55
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 5.49
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 5.44
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 5.44
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 5.43
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 5.41
Fibroblasts in cholesteatoma activate osteoclasts. 5.41
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 5.4
NKX2.2 5.4
RNA-seq of RKO cells with cTAZ KO or putback 5.38
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 5.37
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 5.35
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 5.34
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 5.34
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 5.32
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 5.32
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 5.29
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 5.27
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 5.25
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 5.25
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 5.23
RNA-seq analysis of differentiating human erythroblasts 5.21
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 5.18
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 5.18
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 5.15
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 5.15
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 5.13
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 5.12
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 4.99
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 4.99
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 4.97
MARCKS and lnc-MARCKS act as inflammation regulators 4.91
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 4.88
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 4.86
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 4.86
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 4.86
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 4.84
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 4.82
UBC9 knockdown in bladder cancer T24 cell lines 4.76
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 4.75
PRDM1 inhibits proliferation of human colon cancer organoids 4.75
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 4.74
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 4.73
SRSF1 role in cellular gene expression and splicing 4.7
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 4.7
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 4.65
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 4.59
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 4.58
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 4.51
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 4.5
Transcriptome wide analysis of classically and alternatively activated macrophages 4.49
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 4.43
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 4.41
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 4.41
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 4.37
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 4.36
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 4.36
Human neutrophil genome during PMA- and E. coli encounter-induced activation 4.36
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 4.34
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 4.28
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 4.27
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 4.26
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 4.19
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 4.15
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 4.13
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 4.13
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 4.13
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 4.11
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 4.09
NHLRC1 re-expression in cancer cells 4.06
Effect of PBK knockdown on C4-2 cell transcriptome 4.02
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 4.01
MicroRNA-125a-5p overexpression in human macrophages 4.01
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 4.0
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 3.98
RNA-Seq in neutrophils from Antiphospholipid Syndrome 3.94
A transcriptome dataset revealing the molecular features of breast cancer stem cells 3.89
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 3.88
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 3.87
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 3.87
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 3.86
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 3.85
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 3.83
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 3.81
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 3.76
Transcriptomes of human monocytes after ex vivo exposure to uric acid 3.64
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 3.6
Transcriptome of Stabilin-1 siRNA transfected human monocytes 3.59
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 3.58
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 3.58
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 3.53
Transcriptome analysis of virus infected tissues 3.52
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 3.51
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 3.49
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 3.46
Transcriptome of activated human and mouse MAIT cells 3.41
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 3.38
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 3.36
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 3.36
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 3.33
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 3.31
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 3.2
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 3.15
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 3.15
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.03
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.03
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 3.01
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 3.01
Systematic discovery of endogenous human ribonucleoprotein complexes 2.82
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 2.79
RNA-Seq from human ILC transitional populations 2.76
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 2.76
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 2.76
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 2.74
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 2.74
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 2.74
Primate transcript and protein expression levels evolve under compensatory selection pressures 2.68
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 2.67
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 2.66
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 2.66
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 2.65
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 2.64
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 2.64
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 2.62
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 2.58
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 2.58
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 2.57
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 2.54
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 2.52
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 2.48
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 2.45
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 2.45
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 2.42
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 2.42
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.42
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 2.38
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 2.38
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 2.36
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 2.36
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 2.35
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 2.33
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 2.32
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 2.31
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 2.28
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 2.26
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 2.25
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.24
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 2.24
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 2.21
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 2.2
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 2.16
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 2.15
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 2.11
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 2.01
Comparative Analysis of Cas9 Activators Across Multiple Species 1.96
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 1.95
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 1.9
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 1.9
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.78
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.78
The Genetic Landscape of Diamond-Blackfan Anemia 1.75
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.75
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.75
siRNA-mediated knockdown 1.72
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 1.71
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 1.67
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 1.67
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 1.66
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 1.59
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 1.46
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 1.45
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 1.45
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.45
naive T cell heterogeneity after neonatal thymectomy 1.39
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 1.39
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.38
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 1.32
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 1.32
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 1.31
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 1.28
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 1.24
SNHG5 siRNA knock down in HCT116 cells 1.24
Aging-associated patterns in the expression of human endogenous retroviruses 1.21
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 1.21
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 1.17
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 1.14
The DPYSL2 gene connects mTOR and schizophrenia 1.09
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.02
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.02
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.02
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 1.01
Role of cervicovaginal microbiota in genital inflammation 0.97
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 0.93
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 0.88
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 0.87
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 0.87
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.85
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.79
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.77
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.76
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.75
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 0.71
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.65
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.64
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.57
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.56
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.56
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 0.52
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 0.52
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.48
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 0.43
Transcriptomic analysis of human macrophages in 3D 0.38
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 0.36
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 0.36
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.33
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.33
HNRNPM-regulated splicing dependencies in prostate cancer 0.33
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.31
Loss of CREBBP results in gene expression repression in lymphoma cells 0.31
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.3
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.28
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.26
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.22
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.22
Transcriptomic analysis of frontal fibrosing alopecia 0.22
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.2
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.16
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.15
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.13
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.13
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.13
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.13
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 0.12
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.11
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 0.08
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.07
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.07
Modulation of nonsense-mediated decay by rapamycin 0.06
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.05
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.04
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 0.02
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 0.02
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 0.01
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 0.01
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.01
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation